Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the open label study is to assess long term safety and tolerability of PR OROS methylphenidate in a flexible dose regimen (18-90 mg/day) in adult subjects diagnosed with ADHD.
Critère d'inclusion
- Attention-Deficit/Hyperactivity Disorder (ADHD)